The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.
Showing results 1 - 10 of 110
Rapid Assessment on Access to PrEP in EU/EEA Countries
This report by AIDS Action Europe summarizes the results of a survey of member organizations and partners based in EU Member States on various aspects of availability, accessibility, affordability, and acceptability of PrEP in their national context. In addition to the main findings, it includes country profiles and recommendations for the European Union and its…
Mapping Implementation Science with Expert Recommendations for Implementing Change (MIS-ERIC): Strategies to Improve PrEP Use among Black Cisgender Women Living in Mississippi
This article from the Journal of Racial and Ethnic Health Disparities describes an analysis of qualitative interviews undertaken in Mississippi, USA with Black, cisgender women at risk for HIV and community healthcare clinic staff who work directly with this population in order to identify barriers to PrEP uptake and select appropriate implementation strategies to increase…
Demand Creation/Marketing, Research, Service Delivery
MATRIX Project Overview
This factsheet provides an overview of USAID’s Microbicide Research and Development to Advance HIV Prevention Technologies through Responsive Innovations and Excellence (MATRIX) project.
Exploring the Use of Oral PrEP Among Women from Durban, South Africa as Part of the HIV Prevention Package in a Clinical Trial
This article from AIDS and Behavior explores PrEP use and post-trial PrEP access amongst women who had taken part in the Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial in Durban, South Africa, and describes barriers to access.
Results of 90 Day Tenofovir plus Levonorgestrel Vaginal Ring Trial: The CONRAD 138 study
This article from PLOS One presents the results of a randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics, and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women to prevent both pregnancy and HIV.
Private Sector Delivery Opportunities for the Dual Prevention Pill
This scoping report provides an updated assessment of the private sector delivery options for the dual prevention pill (DPP) in the three countries that are targeted for the initial roll out of the DPP: Kenya, South Africa, and Zimbabwe. The report builds upon previous assessments and analysis that the DPP Consortium have carried out recently,…
Blazing a trail for MPT counseling: Efforts to develop recommendations for the Dual Prevention Pill and reconcile inconsistent guidance for delivering PrEP and oral contraception
This poster from AIDS 2022 describes a process for future efforts to develop appropriate counseling guidance for Multipurpose Technologies, based on learnings from the Dual Prevention Pill and using missed pills as an illustrative example.
Community/Advocacy, Service Delivery
How Market Preparation for the Dual Prevention Pill is Reimagining Prevention Programs for a Future with MPTs
This slide deck presentation from AIDS 2022 describes how prevention programs can prepare for multipurpose prevention technology (MPTs) such as the Dual Prevention Pill, which combines protection against pregnancy and HIV, and offers marketing insights. The session also presents recommendations for provider counseling on a combined product. Watch the full session from AIDS 2022 here.
Community/Advocacy, Service Delivery
By women, for women: A story of rings, research and resolve
This dynamic photo story from the International Partnership for Microbicides explains how the dapivirine vaginal ring was conceived, and the journey it has taken to becoming an HIV prevention choice for women.
Plan 4 Ring Toolkit: Considerations for Monitoring and Evaluation
In the context of the introduction of the dapivirine ring, this document examines the challenges posed by the current PrEP indicators, proposes new indicators for consideration, and describes how the new indicators would be calculated and used. This tool is part of the Plan 4 Ring toolkit, a suite of resources and tools designed to…
Monitoring & Evaluation